SEC-sourced researchBeta
BTMD
biote Corp.
Company comparison ↗
Data passport
- CIK
- 0001819253
- Exchange
- Nasdaq
- Business activity
- Medicinal Chemicals & Botanical Products · SIC 2833
- Financial inputs
- 6/6
- Filing date
- Nov 12, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 197,191,000.0000 | Mar 13, 2026 |
| December 2025 | 192,219,000.0000 | Mar 13, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 192,219,000.0000 | 27,045,000.0000 | 35,194,000.0000 | 107,613,000.0000 | 158,010,000.0000 | Mar 13, 2026 |
| December 2024 | 197,191,000.0000 | 3,157,000.0000 | 45,243,000.0000 | 122,370,000.0000 | 224,570,000.0000 | Mar 13, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
62/100
Profitability78
Growth47
Balance sheet0
Cash generation87
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $192.22M | Jan 1, 2025 – Dec 31, 2025 | Mar 13, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $197.19M | Jan 1, 2024 – Dec 31, 2024 | Mar 13, 2026 | 10-K |
| Net incomeNetIncomeLoss | $27.05M | Jan 1, 2025 – Dec 31, 2025 | Mar 13, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $35.19M | Jan 1, 2025 – Dec 31, 2025 | Mar 13, 2026 | 10-K |
| Total assetsAssets | $107.61M | Dec 31, 2025 | Mar 13, 2026 | 10-K |
| Total liabilitiesLiabilities | $158.01M | Dec 31, 2025 | Mar 13, 2026 | 10-K |